nodes	percent_of_prediction	percent_of_DWPC	metapath
Bepridil—ABCB1—Dactinomycin—sarcoma	0.015	0.262	CbGbCtD
Bepridil—ABCB1—Mitoxantrone—sarcoma	0.0135	0.234	CbGbCtD
Bepridil—ABCB1—Vincristine—sarcoma	0.00926	0.161	CbGbCtD
Bepridil—ABCB1—Etoposide—sarcoma	0.00849	0.148	CbGbCtD
Bepridil—CACNA2D2—mammary gland—sarcoma	0.00723	0.0307	CbGeAlD
Bepridil—ABCB1—Doxorubicin—sarcoma	0.00579	0.101	CbGbCtD
Bepridil—CYP2D6—Doxorubicin—sarcoma	0.00545	0.0949	CbGbCtD
Bepridil—TNNC1—hematopoietic system—sarcoma	0.00524	0.0222	CbGeAlD
Bepridil—TNNC1—connective tissue—sarcoma	0.00504	0.0214	CbGeAlD
Bepridil—Sinus bradycardia—Mitoxantrone—sarcoma	0.00487	0.0274	CcSEcCtD
Bepridil—Sudden death—Mitoxantrone—sarcoma	0.00467	0.0262	CcSEcCtD
Bepridil—KCNQ1—seminal vesicle—sarcoma	0.00448	0.019	CbGeAlD
Bepridil—CACNA1H—myometrium—sarcoma	0.00416	0.0176	CbGeAlD
Bepridil—PDE1A—smooth muscle tissue—sarcoma	0.00403	0.0171	CbGeAlD
Bepridil—TNNC1—cardiac atrium—sarcoma	0.00398	0.0169	CbGeAlD
Bepridil—CACNA1H—seminal vesicle—sarcoma	0.00376	0.0159	CbGeAlD
Bepridil—CALM3—mammary gland—sarcoma	0.00374	0.0159	CbGeAlD
Bepridil—CALM2—endothelium—sarcoma	0.00365	0.0155	CbGeAlD
Bepridil—CALM1—endothelium—sarcoma	0.00363	0.0154	CbGeAlD
Bepridil—TNNC1—tendon—sarcoma	0.00347	0.0147	CbGeAlD
Bepridil—PDE1A—uterus—sarcoma	0.00346	0.0147	CbGeAlD
Bepridil—CACNA1A—testis—sarcoma	0.00343	0.0145	CbGeAlD
Bepridil—CACNA2D2—cardiac atrium—sarcoma	0.00335	0.0142	CbGeAlD
Bepridil—ATP1A1—mammary gland—sarcoma	0.00334	0.0142	CbGeAlD
Bepridil—KCNQ1—cardiac atrium—sarcoma	0.00323	0.0137	CbGeAlD
Bepridil—CACNA1C—myometrium—sarcoma	0.00317	0.0134	CbGeAlD
Bepridil—CACNA1H—smooth muscle tissue—sarcoma	0.00315	0.0133	CbGeAlD
Bepridil—PDE1A—tendon—sarcoma	0.00303	0.0128	CbGeAlD
Bepridil—PDE1B—testis—sarcoma	0.00299	0.0127	CbGeAlD
Bepridil—CALM1—mammary gland—sarcoma	0.00293	0.0124	CbGeAlD
Bepridil—TNNC1—testis—sarcoma	0.00287	0.0122	CbGeAlD
Bepridil—Sinus tachycardia—Epirubicin—sarcoma	0.00277	0.0155	CcSEcCtD
Bepridil—KCNQ1—bone marrow—sarcoma	0.00273	0.0116	CbGeAlD
Bepridil—CACNA1H—uterus—sarcoma	0.0027	0.0114	CbGeAlD
Bepridil—CALM3—myometrium—sarcoma	0.00266	0.0113	CbGeAlD
Bepridil—CACNA1C—connective tissue—sarcoma	0.00262	0.0111	CbGeAlD
Bepridil—Sinus tachycardia—Doxorubicin—sarcoma	0.00256	0.0144	CcSEcCtD
Bepridil—PDE1A—testis—sarcoma	0.00251	0.0106	CbGeAlD
Bepridil—CACNA2D2—testis—sarcoma	0.00241	0.0102	CbGeAlD
Bepridil—CALM3—seminal vesicle—sarcoma	0.0024	0.0102	CbGeAlD
Bepridil—CACNA1C—smooth muscle tissue—sarcoma	0.0024	0.0102	CbGeAlD
Bepridil—PDE1A—liver—sarcoma	0.00237	0.0101	CbGeAlD
Bepridil—ATP1A1—myometrium—sarcoma	0.00237	0.01	CbGeAlD
Bepridil—KCNQ1—testis—sarcoma	0.00233	0.00989	CbGeAlD
Bepridil—ATP1A1—embryo—sarcoma	0.00228	0.00966	CbGeAlD
Bepridil—CACNA1D—cardiac atrium—sarcoma	0.00224	0.00949	CbGeAlD
Bepridil—KCNQ1—liver—sarcoma	0.0022	0.00935	CbGeAlD
Bepridil—PDE1B—lymph node—sarcoma	0.00217	0.0092	CbGeAlD
Bepridil—ATP1A1—seminal vesicle—sarcoma	0.00214	0.00907	CbGeAlD
Bepridil—CALM2—myometrium—sarcoma	0.00209	0.00884	CbGeAlD
Bepridil—TNNC1—lymph node—sarcoma	0.00208	0.00882	CbGeAlD
Bepridil—CALM1—myometrium—sarcoma	0.00208	0.0088	CbGeAlD
Bepridil—CACNA1C—cardiac atrium—sarcoma	0.00207	0.00876	CbGeAlD
Bepridil—Cardiac failure—Thiotepa—sarcoma	0.00206	0.0116	CcSEcCtD
Bepridil—ATP1A1—hematopoietic system—sarcoma	0.00203	0.00862	CbGeAlD
Bepridil—CALM3—smooth muscle tissue—sarcoma	0.00201	0.00852	CbGeAlD
Bepridil—CALM2—embryo—sarcoma	0.00201	0.0085	CbGeAlD
Bepridil—CALM1—embryo—sarcoma	0.002	0.00847	CbGeAlD
Bepridil—CACNA1H—testis—sarcoma	0.00196	0.0083	CbGeAlD
Bepridil—ATP1A1—connective tissue—sarcoma	0.00196	0.0083	CbGeAlD
Bepridil—KCNH2—myometrium—sarcoma	0.00189	0.00801	CbGeAlD
Bepridil—CALM2—seminal vesicle—sarcoma	0.00188	0.00799	CbGeAlD
Bepridil—CACNA1H—liver—sarcoma	0.00185	0.00785	CbGeAlD
Bepridil—Liver function test abnormal—Dactinomycin—sarcoma	0.00184	0.0103	CcSEcCtD
Bepridil—PDE1A—lymph node—sarcoma	0.00182	0.00771	CbGeAlD
Bepridil—ATP1A1—smooth muscle tissue—sarcoma	0.00179	0.00759	CbGeAlD
Bepridil—CALM2—hematopoietic system—sarcoma	0.00179	0.00759	CbGeAlD
Bepridil—CALM1—hematopoietic system—sarcoma	0.00178	0.00756	CbGeAlD
Bepridil—Cardiac failure—Mitoxantrone—sarcoma	0.00178	0.00999	CcSEcCtD
Bepridil—ATP1A1—skin of body—sarcoma	0.00177	0.0075	CbGeAlD
Bepridil—CACNA2D2—lymph node—sarcoma	0.00175	0.00742	CbGeAlD
Bepridil—CALM3—cardiac atrium—sarcoma	0.00173	0.00734	CbGeAlD
Bepridil—CALM2—connective tissue—sarcoma	0.00172	0.00731	CbGeAlD
Bepridil—CALM3—uterus—sarcoma	0.00172	0.0073	CbGeAlD
Bepridil—CALM1—connective tissue—sarcoma	0.00172	0.00728	CbGeAlD
Bepridil—KCNH2—seminal vesicle—sarcoma	0.00171	0.00724	CbGeAlD
Bepridil—KCNQ1—lymph node—sarcoma	0.00169	0.00717	CbGeAlD
Bepridil—KCNH2—hematopoietic system—sarcoma	0.00162	0.00688	CbGeAlD
Bepridil—CACNA1D—testis—sarcoma	0.00162	0.00685	CbGeAlD
Bepridil—CALM2—smooth muscle tissue—sarcoma	0.00158	0.00669	CbGeAlD
Bepridil—CALM1—smooth muscle tissue—sarcoma	0.00157	0.00666	CbGeAlD
Bepridil—CALM2—skin of body—sarcoma	0.00156	0.0066	CbGeAlD
Bepridil—CALM1—skin of body—sarcoma	0.00155	0.00657	CbGeAlD
Bepridil—ATP1A1—cardiac atrium—sarcoma	0.00154	0.00655	CbGeAlD
Bepridil—ATP1A1—uterus—sarcoma	0.00154	0.00651	CbGeAlD
Bepridil—CACNA1D—liver—sarcoma	0.00153	0.00648	CbGeAlD
Bepridil—CALM3—tendon—sarcoma	0.00151	0.0064	CbGeAlD
Bepridil—Ventricular arrhythmia—Epirubicin—sarcoma	0.00151	0.00846	CcSEcCtD
Bepridil—CACNA1C—testis—sarcoma	0.00149	0.00633	CbGeAlD
Bepridil—Cardiac failure—Etoposide—sarcoma	0.00148	0.00831	CcSEcCtD
Bepridil—CALM3—bone marrow—sarcoma	0.00146	0.0062	CbGeAlD
Bepridil—ATP1A1—lymphoid tissue—sarcoma	0.00143	0.00607	CbGeAlD
Bepridil—CACNA1H—lymph node—sarcoma	0.00142	0.00602	CbGeAlD
Bepridil—Erectile dysfunction—Vincristine—sarcoma	0.00142	0.00797	CcSEcCtD
Bepridil—Ventricular arrhythmia—Doxorubicin—sarcoma	0.00139	0.00783	CcSEcCtD
Bepridil—Erectile dysfunction—Mitoxantrone—sarcoma	0.00138	0.00776	CcSEcCtD
Bepridil—Pharyngitis—Dactinomycin—sarcoma	0.00137	0.00769	CcSEcCtD
Bepridil—Depression—Vincristine—sarcoma	0.00137	0.00769	CcSEcCtD
Bepridil—CALM2—cardiac atrium—sarcoma	0.00136	0.00576	CbGeAlD
Bepridil—CALM1—cardiac atrium—sarcoma	0.00135	0.00574	CbGeAlD
Bepridil—CALM2—uterus—sarcoma	0.00135	0.00573	CbGeAlD
Bepridil—CALM1—uterus—sarcoma	0.00135	0.00571	CbGeAlD
Bepridil—ATP1A1—tendon—sarcoma	0.00135	0.00571	CbGeAlD
Bepridil—Drowsiness—Mitoxantrone—sarcoma	0.00134	0.00751	CcSEcCtD
Bepridil—Sweating—Vincristine—sarcoma	0.00132	0.0074	CcSEcCtD
Bepridil—ATP1A1—bone marrow—sarcoma	0.0013	0.00553	CbGeAlD
Bepridil—Tinnitus—Thiotepa—sarcoma	0.0013	0.00728	CcSEcCtD
Bepridil—Cardiac disorder—Thiotepa—sarcoma	0.00129	0.00725	CcSEcCtD
Bepridil—Sweating—Mitoxantrone—sarcoma	0.00128	0.0072	CcSEcCtD
Bepridil—Vasodilation procedure—Epirubicin—sarcoma	0.00127	0.00713	CcSEcCtD
Bepridil—Vasodilation—Epirubicin—sarcoma	0.00127	0.00713	CcSEcCtD
Bepridil—CALM2—lymphoid tissue—sarcoma	0.00126	0.00535	CbGeAlD
Bepridil—CALM1—lymphoid tissue—sarcoma	0.00126	0.00532	CbGeAlD
Bepridil—CALM3—testis—sarcoma	0.00125	0.0053	CbGeAlD
Bepridil—Arrhythmia—Thiotepa—sarcoma	0.00124	0.00698	CcSEcCtD
Bepridil—KCNH2—cardiac atrium—sarcoma	0.00123	0.00522	CbGeAlD
Bepridil—KCNH2—uterus—sarcoma	0.00123	0.00519	CbGeAlD
Bepridil—Bradycardia—Mitoxantrone—sarcoma	0.00122	0.00687	CcSEcCtD
Bepridil—Rhinitis—Mitoxantrone—sarcoma	0.0012	0.00676	CcSEcCtD
Bepridil—Pharyngitis—Mitoxantrone—sarcoma	0.00119	0.00669	CcSEcCtD
Bepridil—Tension—Thiotepa—sarcoma	0.00119	0.00667	CcSEcCtD
Bepridil—CALM2—tendon—sarcoma	0.00119	0.00502	CbGeAlD
Bepridil—CALM3—liver—sarcoma	0.00118	0.00501	CbGeAlD
Bepridil—CALM1—tendon—sarcoma	0.00118	0.005	CbGeAlD
Bepridil—Nervousness—Thiotepa—sarcoma	0.00117	0.0066	CcSEcCtD
Bepridil—Vasodilation—Doxorubicin—sarcoma	0.00117	0.0066	CcSEcCtD
Bepridil—Vasodilation procedure—Doxorubicin—sarcoma	0.00117	0.0066	CcSEcCtD
Bepridil—CACNA1D—lymph node—sarcoma	0.00117	0.00497	CbGeAlD
Bepridil—CALM2—bone marrow—sarcoma	0.00115	0.00487	CbGeAlD
Bepridil—Cardiac disorder—Vincristine—sarcoma	0.00114	0.00643	CcSEcCtD
Bepridil—CALM1—bone marrow—sarcoma	0.00114	0.00484	CbGeAlD
Bepridil—Vision blurred—Thiotepa—sarcoma	0.00114	0.00641	CcSEcCtD
Bepridil—ATP1A1—testis—sarcoma	0.00111	0.00472	CbGeAlD
Bepridil—Ventricular tachycardia—Epirubicin—sarcoma	0.00111	0.00626	CcSEcCtD
Bepridil—CACNA1C—lymph node—sarcoma	0.00108	0.00458	CbGeAlD
Bepridil—Arrhythmia—Mitoxantrone—sarcoma	0.00107	0.00603	CcSEcCtD
Bepridil—Cough—Thiotepa—sarcoma	0.00106	0.00593	CcSEcCtD
Bepridil—ATP1A1—liver—sarcoma	0.00105	0.00447	CbGeAlD
Bepridil—Hypertension—Thiotepa—sarcoma	0.00104	0.00587	CcSEcCtD
Bepridil—KCNH2—bone marrow—sarcoma	0.00104	0.00441	CbGeAlD
Bepridil—Ventricular tachycardia—Doxorubicin—sarcoma	0.00103	0.0058	CcSEcCtD
Bepridil—Myalgia—Thiotepa—sarcoma	0.00103	0.00579	CcSEcCtD
Bepridil—Anxiety—Thiotepa—sarcoma	0.00103	0.00577	CcSEcCtD
Bepridil—Myalgia—Dactinomycin—sarcoma	0.00102	0.00575	CcSEcCtD
Bepridil—CYP2D6—hematopoietic system—sarcoma	0.000989	0.00419	CbGeAlD
Bepridil—Vision blurred—Mitoxantrone—sarcoma	0.000984	0.00553	CcSEcCtD
Bepridil—CALM2—testis—sarcoma	0.000982	0.00416	CbGeAlD
Bepridil—Oedema—Dactinomycin—sarcoma	0.00098	0.00551	CcSEcCtD
Bepridil—CALM1—testis—sarcoma	0.000977	0.00414	CbGeAlD
Bepridil—Vertigo—Vincristine—sarcoma	0.000964	0.00542	CcSEcCtD
Bepridil—Anorexia—Thiotepa—sarcoma	0.000941	0.00529	CcSEcCtD
Bepridil—Anorexia—Dactinomycin—sarcoma	0.000934	0.00525	CcSEcCtD
Bepridil—CALM2—liver—sarcoma	0.000928	0.00393	CbGeAlD
Bepridil—Cardiac disorder—Etoposide—sarcoma	0.000926	0.00521	CcSEcCtD
Bepridil—Hypertension—Vincristine—sarcoma	0.000926	0.00521	CcSEcCtD
Bepridil—CALM1—liver—sarcoma	0.000924	0.00392	CbGeAlD
Bepridil—Myalgia—Vincristine—sarcoma	0.000913	0.00513	CcSEcCtD
Bepridil—Cough—Mitoxantrone—sarcoma	0.000911	0.00512	CcSEcCtD
Bepridil—CALM3—lymph node—sarcoma	0.000906	0.00384	CbGeAlD
Bepridil—Hypertension—Mitoxantrone—sarcoma	0.000902	0.00507	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Thiotepa—sarcoma	0.000899	0.00506	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Dactinomycin—sarcoma	0.000893	0.00502	CcSEcCtD
Bepridil—Myalgia—Mitoxantrone—sarcoma	0.000889	0.005	CcSEcCtD
Bepridil—KCNH2—testis—sarcoma	0.000889	0.00377	CbGeAlD
Bepridil—Paraesthesia—Thiotepa—sarcoma	0.000886	0.00498	CcSEcCtD
Bepridil—Anxiety—Mitoxantrone—sarcoma	0.000886	0.00498	CcSEcCtD
Bepridil—Somnolence—Thiotepa—sarcoma	0.000878	0.00493	CcSEcCtD
Bepridil—Oedema—Vincristine—sarcoma	0.000875	0.00492	CcSEcCtD
Bepridil—Dyspepsia—Thiotepa—sarcoma	0.000869	0.00488	CcSEcCtD
Bepridil—Increased appetite—Epirubicin—sarcoma	0.000861	0.00484	CcSEcCtD
Bepridil—Decreased appetite—Thiotepa—sarcoma	0.000858	0.00482	CcSEcCtD
Bepridil—Oedema—Mitoxantrone—sarcoma	0.000852	0.00479	CcSEcCtD
Bepridil—Gastrointestinal disorder—Thiotepa—sarcoma	0.000852	0.00479	CcSEcCtD
Bepridil—Decreased appetite—Dactinomycin—sarcoma	0.000852	0.00479	CcSEcCtD
Bepridil—Hyperhidrosis—Vincristine—sarcoma	0.000846	0.00476	CcSEcCtD
Bepridil—Constipation—Thiotepa—sarcoma	0.000844	0.00475	CcSEcCtD
Bepridil—Pain—Thiotepa—sarcoma	0.000844	0.00475	CcSEcCtD
Bepridil—Shock—Mitoxantrone—sarcoma	0.000839	0.00471	CcSEcCtD
Bepridil—Pain—Dactinomycin—sarcoma	0.000838	0.00471	CcSEcCtD
Bepridil—Anorexia—Vincristine—sarcoma	0.000834	0.00469	CcSEcCtD
Bepridil—ABCB1—myometrium—sarcoma	0.000829	0.00351	CbGeAlD
Bepridil—Cardiac failure—Epirubicin—sarcoma	0.000829	0.00466	CcSEcCtD
Bepridil—Hyperhidrosis—Mitoxantrone—sarcoma	0.000824	0.00463	CcSEcCtD
Bepridil—Anorexia—Mitoxantrone—sarcoma	0.000813	0.00457	CcSEcCtD
Bepridil—ATP1A1—lymph node—sarcoma	0.000808	0.00342	CbGeAlD
Bepridil—Gastrointestinal pain—Thiotepa—sarcoma	0.000807	0.00454	CcSEcCtD
Bepridil—Gastrointestinal pain—Dactinomycin—sarcoma	0.000801	0.0045	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Vincristine—sarcoma	0.000798	0.00448	CcSEcCtD
Bepridil—ABCB1—embryo—sarcoma	0.000797	0.00338	CbGeAlD
Bepridil—Increased appetite—Doxorubicin—sarcoma	0.000796	0.00448	CcSEcCtD
Bepridil—Insomnia—Vincristine—sarcoma	0.000792	0.00445	CcSEcCtD
Bepridil—Paraesthesia—Vincristine—sarcoma	0.000786	0.00442	CcSEcCtD
Bepridil—Vertigo—Etoposide—sarcoma	0.000781	0.00439	CcSEcCtD
Bepridil—Body temperature increased—Thiotepa—sarcoma	0.00078	0.00439	CcSEcCtD
Bepridil—Abdominal pain—Thiotepa—sarcoma	0.00078	0.00439	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000777	0.00437	CcSEcCtD
Bepridil—Abdominal pain—Dactinomycin—sarcoma	0.000775	0.00435	CcSEcCtD
Bepridil—Body temperature increased—Dactinomycin—sarcoma	0.000775	0.00435	CcSEcCtD
Bepridil—Cardiac failure—Doxorubicin—sarcoma	0.000767	0.00431	CcSEcCtD
Bepridil—Paraesthesia—Mitoxantrone—sarcoma	0.000765	0.0043	CcSEcCtD
Bepridil—Loss of consciousness—Etoposide—sarcoma	0.000764	0.00429	CcSEcCtD
Bepridil—Decreased appetite—Vincristine—sarcoma	0.000761	0.00428	CcSEcCtD
Bepridil—Dyspnoea—Mitoxantrone—sarcoma	0.00076	0.00427	CcSEcCtD
Bepridil—Cough—Etoposide—sarcoma	0.000758	0.00426	CcSEcCtD
Bepridil—Somnolence—Mitoxantrone—sarcoma	0.000758	0.00426	CcSEcCtD
Bepridil—Gastrointestinal disorder—Vincristine—sarcoma	0.000756	0.00425	CcSEcCtD
Bepridil—Dyspepsia—Mitoxantrone—sarcoma	0.00075	0.00422	CcSEcCtD
Bepridil—Hypertension—Etoposide—sarcoma	0.00075	0.00422	CcSEcCtD
Bepridil—ABCB1—seminal vesicle—sarcoma	0.000749	0.00317	CbGeAlD
Bepridil—Pain—Vincristine—sarcoma	0.000749	0.00421	CcSEcCtD
Bepridil—Constipation—Vincristine—sarcoma	0.000749	0.00421	CcSEcCtD
Bepridil—Liver function test abnormal—Epirubicin—sarcoma	0.000747	0.0042	CcSEcCtD
Bepridil—Decreased appetite—Mitoxantrone—sarcoma	0.000741	0.00417	CcSEcCtD
Bepridil—Constipation—Mitoxantrone—sarcoma	0.000729	0.0041	CcSEcCtD
Bepridil—Pain—Mitoxantrone—sarcoma	0.000729	0.0041	CcSEcCtD
Bepridil—Gastrointestinal pain—Vincristine—sarcoma	0.000716	0.00402	CcSEcCtD
Bepridil—Gastritis—Epirubicin—sarcoma	0.000716	0.00402	CcSEcCtD
Bepridil—ABCB1—hematopoietic system—sarcoma	0.000712	0.00302	CbGeAlD
Bepridil—CALM2—lymph node—sarcoma	0.000711	0.00302	CbGeAlD
Bepridil—Asthenia—Thiotepa—sarcoma	0.000708	0.00398	CcSEcCtD
Bepridil—CALM1—lymph node—sarcoma	0.000708	0.003	CbGeAlD
Bepridil—Asthenia—Dactinomycin—sarcoma	0.000703	0.00395	CcSEcCtD
Bepridil—Influenza—Epirubicin—sarcoma	0.000699	0.00393	CcSEcCtD
Bepridil—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000697	0.00392	CcSEcCtD
Bepridil—Body temperature increased—Vincristine—sarcoma	0.000692	0.00389	CcSEcCtD
Bepridil—Abdominal pain—Vincristine—sarcoma	0.000692	0.00389	CcSEcCtD
Bepridil—Liver function test abnormal—Doxorubicin—sarcoma	0.000691	0.00388	CcSEcCtD
Bepridil—Hyperhidrosis—Etoposide—sarcoma	0.000686	0.00385	CcSEcCtD
Bepridil—Angina pectoris—Epirubicin—sarcoma	0.000681	0.00383	CcSEcCtD
Bepridil—Anorexia—Etoposide—sarcoma	0.000676	0.0038	CcSEcCtD
Bepridil—Diarrhoea—Thiotepa—sarcoma	0.000675	0.0038	CcSEcCtD
Bepridil—Body temperature increased—Mitoxantrone—sarcoma	0.000674	0.00379	CcSEcCtD
Bepridil—Abdominal pain—Mitoxantrone—sarcoma	0.000674	0.00379	CcSEcCtD
Bepridil—Diarrhoea—Dactinomycin—sarcoma	0.00067	0.00377	CcSEcCtD
Bepridil—Gastritis—Doxorubicin—sarcoma	0.000662	0.00372	CcSEcCtD
Bepridil—Dizziness—Thiotepa—sarcoma	0.000653	0.00367	CcSEcCtD
Bepridil—Influenza—Doxorubicin—sarcoma	0.000647	0.00364	CcSEcCtD
Bepridil—KCNH2—lymph node—sarcoma	0.000645	0.00273	CbGeAlD
Bepridil—Paraesthesia—Etoposide—sarcoma	0.000637	0.00358	CcSEcCtD
Bepridil—Dyspnoea—Etoposide—sarcoma	0.000632	0.00355	CcSEcCtD
Bepridil—Somnolence—Etoposide—sarcoma	0.00063	0.00354	CcSEcCtD
Bepridil—Angina pectoris—Doxorubicin—sarcoma	0.00063	0.00354	CcSEcCtD
Bepridil—Asthenia—Vincristine—sarcoma	0.000628	0.00353	CcSEcCtD
Bepridil—Drowsiness—Epirubicin—sarcoma	0.000623	0.0035	CcSEcCtD
Bepridil—Rash—Thiotepa—sarcoma	0.000622	0.0035	CcSEcCtD
Bepridil—Dermatitis—Thiotepa—sarcoma	0.000622	0.0035	CcSEcCtD
Bepridil—Headache—Thiotepa—sarcoma	0.000618	0.00348	CcSEcCtD
Bepridil—Rash—Dactinomycin—sarcoma	0.000618	0.00347	CcSEcCtD
Bepridil—Decreased appetite—Etoposide—sarcoma	0.000616	0.00347	CcSEcCtD
Bepridil—Gastrointestinal disorder—Etoposide—sarcoma	0.000612	0.00344	CcSEcCtD
Bepridil—Asthenia—Mitoxantrone—sarcoma	0.000612	0.00344	CcSEcCtD
Bepridil—Constipation—Etoposide—sarcoma	0.000606	0.00341	CcSEcCtD
Bepridil—Pain—Etoposide—sarcoma	0.000606	0.00341	CcSEcCtD
Bepridil—Diarrhoea—Vincristine—sarcoma	0.000599	0.00337	CcSEcCtD
Bepridil—Sweating—Epirubicin—sarcoma	0.000597	0.00336	CcSEcCtD
Bepridil—Nausea—Thiotepa—sarcoma	0.000586	0.0033	CcSEcCtD
Bepridil—Diarrhoea—Mitoxantrone—sarcoma	0.000583	0.00328	CcSEcCtD
Bepridil—Nausea—Dactinomycin—sarcoma	0.000582	0.00327	CcSEcCtD
Bepridil—Gastrointestinal pain—Etoposide—sarcoma	0.00058	0.00326	CcSEcCtD
Bepridil—Dizziness—Vincristine—sarcoma	0.000579	0.00325	CcSEcCtD
Bepridil—Drowsiness—Doxorubicin—sarcoma	0.000577	0.00324	CcSEcCtD
Bepridil—Bradycardia—Epirubicin—sarcoma	0.00057	0.0032	CcSEcCtD
Bepridil—Rhinitis—Epirubicin—sarcoma	0.000561	0.00315	CcSEcCtD
Bepridil—Body temperature increased—Etoposide—sarcoma	0.000561	0.00315	CcSEcCtD
Bepridil—Abdominal pain—Etoposide—sarcoma	0.000561	0.00315	CcSEcCtD
Bepridil—Pharyngitis—Epirubicin—sarcoma	0.000555	0.00312	CcSEcCtD
Bepridil—Sweating—Doxorubicin—sarcoma	0.000553	0.00311	CcSEcCtD
Bepridil—Rash—Vincristine—sarcoma	0.000552	0.0031	CcSEcCtD
Bepridil—Dermatitis—Vincristine—sarcoma	0.000551	0.0031	CcSEcCtD
Bepridil—Headache—Vincristine—sarcoma	0.000548	0.00308	CcSEcCtD
Bepridil—CYP2D6—testis—sarcoma	0.000542	0.0023	CbGeAlD
Bepridil—ABCB1—uterus—sarcoma	0.000538	0.00228	CbGeAlD
Bepridil—Rash—Mitoxantrone—sarcoma	0.000538	0.00302	CcSEcCtD
Bepridil—Dermatitis—Mitoxantrone—sarcoma	0.000537	0.00302	CcSEcCtD
Bepridil—Headache—Mitoxantrone—sarcoma	0.000534	0.003	CcSEcCtD
Bepridil—Bradycardia—Doxorubicin—sarcoma	0.000527	0.00296	CcSEcCtD
Bepridil—Tinnitus—Epirubicin—sarcoma	0.000522	0.00293	CcSEcCtD
Bepridil—Nausea—Vincristine—sarcoma	0.00052	0.00292	CcSEcCtD
Bepridil—Cardiac disorder—Epirubicin—sarcoma	0.000519	0.00292	CcSEcCtD
Bepridil—Rhinitis—Doxorubicin—sarcoma	0.000519	0.00292	CcSEcCtD
Bepridil—Pharyngitis—Doxorubicin—sarcoma	0.000514	0.00289	CcSEcCtD
Bepridil—CYP2D6—liver—sarcoma	0.000513	0.00217	CbGeAlD
Bepridil—Asthenia—Etoposide—sarcoma	0.000509	0.00286	CcSEcCtD
Bepridil—Nausea—Mitoxantrone—sarcoma	0.000506	0.00285	CcSEcCtD
Bepridil—ABCB1—lymphoid tissue—sarcoma	0.000501	0.00212	CbGeAlD
Bepridil—Arrhythmia—Epirubicin—sarcoma	0.0005	0.00281	CcSEcCtD
Bepridil—Diarrhoea—Etoposide—sarcoma	0.000485	0.00273	CcSEcCtD
Bepridil—Tinnitus—Doxorubicin—sarcoma	0.000483	0.00271	CcSEcCtD
Bepridil—Cardiac disorder—Doxorubicin—sarcoma	0.00048	0.0027	CcSEcCtD
Bepridil—Flatulence—Epirubicin—sarcoma	0.00048	0.0027	CcSEcCtD
Bepridil—Tension—Epirubicin—sarcoma	0.000478	0.00269	CcSEcCtD
Bepridil—Nervousness—Epirubicin—sarcoma	0.000473	0.00266	CcSEcCtD
Bepridil—Dizziness—Etoposide—sarcoma	0.000469	0.00264	CcSEcCtD
Bepridil—Arrhythmia—Doxorubicin—sarcoma	0.000462	0.0026	CcSEcCtD
Bepridil—Vision blurred—Epirubicin—sarcoma	0.000459	0.00258	CcSEcCtD
Bepridil—ABCB1—bone marrow—sarcoma	0.000456	0.00193	CbGeAlD
Bepridil—Rash—Etoposide—sarcoma	0.000447	0.00251	CcSEcCtD
Bepridil—Dermatitis—Etoposide—sarcoma	0.000447	0.00251	CcSEcCtD
Bepridil—Headache—Etoposide—sarcoma	0.000444	0.0025	CcSEcCtD
Bepridil—Flatulence—Doxorubicin—sarcoma	0.000444	0.0025	CcSEcCtD
Bepridil—Tension—Doxorubicin—sarcoma	0.000442	0.00249	CcSEcCtD
Bepridil—Nervousness—Doxorubicin—sarcoma	0.000438	0.00246	CcSEcCtD
Bepridil—Vertigo—Epirubicin—sarcoma	0.000438	0.00246	CcSEcCtD
Bepridil—Syncope—Epirubicin—sarcoma	0.000437	0.00246	CcSEcCtD
Bepridil—Palpitations—Epirubicin—sarcoma	0.00043	0.00242	CcSEcCtD
Bepridil—Loss of consciousness—Epirubicin—sarcoma	0.000428	0.00241	CcSEcCtD
Bepridil—Cough—Epirubicin—sarcoma	0.000425	0.00239	CcSEcCtD
Bepridil—Vision blurred—Doxorubicin—sarcoma	0.000425	0.00239	CcSEcCtD
Bepridil—Nausea—Etoposide—sarcoma	0.000421	0.00237	CcSEcCtD
Bepridil—Hypertension—Epirubicin—sarcoma	0.00042	0.00236	CcSEcCtD
Bepridil—Myalgia—Epirubicin—sarcoma	0.000415	0.00233	CcSEcCtD
Bepridil—Anxiety—Epirubicin—sarcoma	0.000413	0.00232	CcSEcCtD
Bepridil—Dry mouth—Epirubicin—sarcoma	0.000406	0.00228	CcSEcCtD
Bepridil—Vertigo—Doxorubicin—sarcoma	0.000405	0.00228	CcSEcCtD
Bepridil—Syncope—Doxorubicin—sarcoma	0.000404	0.00227	CcSEcCtD
Bepridil—Palpitations—Doxorubicin—sarcoma	0.000398	0.00224	CcSEcCtD
Bepridil—Oedema—Epirubicin—sarcoma	0.000397	0.00223	CcSEcCtD
Bepridil—Loss of consciousness—Doxorubicin—sarcoma	0.000396	0.00223	CcSEcCtD
Bepridil—Cough—Doxorubicin—sarcoma	0.000393	0.00221	CcSEcCtD
Bepridil—Shock—Epirubicin—sarcoma	0.000391	0.0022	CcSEcCtD
Bepridil—ABCB1—testis—sarcoma	0.00039	0.00165	CbGeAlD
Bepridil—Hypertension—Doxorubicin—sarcoma	0.000389	0.00219	CcSEcCtD
Bepridil—Hyperhidrosis—Epirubicin—sarcoma	0.000384	0.00216	CcSEcCtD
Bepridil—Myalgia—Doxorubicin—sarcoma	0.000384	0.00216	CcSEcCtD
Bepridil—Anxiety—Doxorubicin—sarcoma	0.000382	0.00215	CcSEcCtD
Bepridil—Anorexia—Epirubicin—sarcoma	0.000379	0.00213	CcSEcCtD
Bepridil—Dry mouth—Doxorubicin—sarcoma	0.000375	0.00211	CcSEcCtD
Bepridil—ABCB1—liver—sarcoma	0.000369	0.00156	CbGeAlD
Bepridil—Oedema—Doxorubicin—sarcoma	0.000368	0.00207	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000362	0.00204	CcSEcCtD
Bepridil—Shock—Doxorubicin—sarcoma	0.000362	0.00203	CcSEcCtD
Bepridil—Insomnia—Epirubicin—sarcoma	0.00036	0.00202	CcSEcCtD
Bepridil—Paraesthesia—Epirubicin—sarcoma	0.000357	0.00201	CcSEcCtD
Bepridil—Hyperhidrosis—Doxorubicin—sarcoma	0.000356	0.002	CcSEcCtD
Bepridil—Dyspnoea—Epirubicin—sarcoma	0.000354	0.00199	CcSEcCtD
Bepridil—Somnolence—Epirubicin—sarcoma	0.000353	0.00199	CcSEcCtD
Bepridil—Anorexia—Doxorubicin—sarcoma	0.000351	0.00197	CcSEcCtD
Bepridil—Dyspepsia—Epirubicin—sarcoma	0.00035	0.00197	CcSEcCtD
Bepridil—Decreased appetite—Epirubicin—sarcoma	0.000346	0.00194	CcSEcCtD
Bepridil—Gastrointestinal disorder—Epirubicin—sarcoma	0.000343	0.00193	CcSEcCtD
Bepridil—Pain—Epirubicin—sarcoma	0.00034	0.00191	CcSEcCtD
Bepridil—Constipation—Epirubicin—sarcoma	0.00034	0.00191	CcSEcCtD
Bepridil—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000335	0.00188	CcSEcCtD
Bepridil—Insomnia—Doxorubicin—sarcoma	0.000333	0.00187	CcSEcCtD
Bepridil—Paraesthesia—Doxorubicin—sarcoma	0.00033	0.00186	CcSEcCtD
Bepridil—Dyspnoea—Doxorubicin—sarcoma	0.000328	0.00184	CcSEcCtD
Bepridil—Somnolence—Doxorubicin—sarcoma	0.000327	0.00184	CcSEcCtD
Bepridil—Gastrointestinal pain—Epirubicin—sarcoma	0.000325	0.00183	CcSEcCtD
Bepridil—Dyspepsia—Doxorubicin—sarcoma	0.000324	0.00182	CcSEcCtD
Bepridil—Decreased appetite—Doxorubicin—sarcoma	0.00032	0.0018	CcSEcCtD
Bepridil—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000318	0.00178	CcSEcCtD
Bepridil—Pain—Doxorubicin—sarcoma	0.000315	0.00177	CcSEcCtD
Bepridil—Constipation—Doxorubicin—sarcoma	0.000315	0.00177	CcSEcCtD
Bepridil—Body temperature increased—Epirubicin—sarcoma	0.000314	0.00177	CcSEcCtD
Bepridil—Abdominal pain—Epirubicin—sarcoma	0.000314	0.00177	CcSEcCtD
Bepridil—Gastrointestinal pain—Doxorubicin—sarcoma	0.000301	0.00169	CcSEcCtD
Bepridil—Abdominal pain—Doxorubicin—sarcoma	0.000291	0.00163	CcSEcCtD
Bepridil—Body temperature increased—Doxorubicin—sarcoma	0.000291	0.00163	CcSEcCtD
Bepridil—Asthenia—Epirubicin—sarcoma	0.000285	0.0016	CcSEcCtD
Bepridil—ABCB1—lymph node—sarcoma	0.000283	0.0012	CbGeAlD
Bepridil—Diarrhoea—Epirubicin—sarcoma	0.000272	0.00153	CcSEcCtD
Bepridil—Asthenia—Doxorubicin—sarcoma	0.000264	0.00148	CcSEcCtD
Bepridil—Dizziness—Epirubicin—sarcoma	0.000263	0.00148	CcSEcCtD
Bepridil—Diarrhoea—Doxorubicin—sarcoma	0.000252	0.00141	CcSEcCtD
Bepridil—Rash—Epirubicin—sarcoma	0.000251	0.00141	CcSEcCtD
Bepridil—Dermatitis—Epirubicin—sarcoma	0.00025	0.00141	CcSEcCtD
Bepridil—Headache—Epirubicin—sarcoma	0.000249	0.0014	CcSEcCtD
Bepridil—Dizziness—Doxorubicin—sarcoma	0.000243	0.00137	CcSEcCtD
Bepridil—Nausea—Epirubicin—sarcoma	0.000236	0.00133	CcSEcCtD
Bepridil—Rash—Doxorubicin—sarcoma	0.000232	0.0013	CcSEcCtD
Bepridil—Dermatitis—Doxorubicin—sarcoma	0.000232	0.0013	CcSEcCtD
Bepridil—Headache—Doxorubicin—sarcoma	0.00023	0.0013	CcSEcCtD
Bepridil—Nausea—Doxorubicin—sarcoma	0.000218	0.00123	CcSEcCtD
Bepridil—CALM1—Immune System—PDGFRA—sarcoma	3.78e-05	7.16e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CCND1—sarcoma	3.71e-05	7.02e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—JUN—sarcoma	3.7e-05	7e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FLT1—sarcoma	3.69e-05	6.98e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—FOXO1—sarcoma	3.68e-05	6.95e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—CTNNB1—sarcoma	3.67e-05	6.95e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PDGFRB—sarcoma	3.67e-05	6.94e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—ENO2—sarcoma	3.65e-05	6.91e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—HBA1—sarcoma	3.63e-05	6.86e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PLCG1—sarcoma	3.63e-05	6.86e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling by GPCR—HRAS—sarcoma	3.62e-05	6.84e-05	CbGpPWpGaD
Bepridil—PDE1A—Immune System—HRAS—sarcoma	3.62e-05	6.84e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—PDGFRA—sarcoma	3.61e-05	6.83e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—KRAS—sarcoma	3.59e-05	6.79e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FLT1—sarcoma	3.57e-05	6.75e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FLT1—sarcoma	3.57e-05	6.75e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—JUN—sarcoma	3.57e-05	6.74e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—FOXO1—sarcoma	3.56e-05	6.73e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—FOXO1—sarcoma	3.56e-05	6.73e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—SRC—sarcoma	3.55e-05	6.72e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PDGFRB—sarcoma	3.55e-05	6.71e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PDGFRB—sarcoma	3.55e-05	6.71e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—CTNNB1—sarcoma	3.54e-05	6.69e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PLCG1—sarcoma	3.51e-05	6.64e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PLCG1—sarcoma	3.51e-05	6.64e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—PDGFRA—sarcoma	3.49e-05	6.61e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—PDGFRA—sarcoma	3.49e-05	6.61e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CXCR4—sarcoma	3.49e-05	6.59e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—IL2—sarcoma	3.48e-05	6.58e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—VEGFA—sarcoma	3.46e-05	6.54e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—JUN—sarcoma	3.45e-05	6.52e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—JUN—sarcoma	3.45e-05	6.52e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—ATF1—sarcoma	3.45e-05	6.52e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—SRC—sarcoma	3.44e-05	6.5e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—SRC—sarcoma	3.44e-05	6.5e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—CTNNB1—sarcoma	3.42e-05	6.47e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—CTNNB1—sarcoma	3.42e-05	6.47e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—NRAS—sarcoma	3.42e-05	6.46e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CCND1—sarcoma	3.39e-05	6.42e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—JUN—sarcoma	3.39e-05	6.4e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CXCR4—sarcoma	3.37e-05	6.38e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CXCR4—sarcoma	3.37e-05	6.38e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—CTNNB1—sarcoma	3.36e-05	6.36e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—VEGFA—sarcoma	3.35e-05	6.33e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—VEGFA—sarcoma	3.35e-05	6.33e-05	CbGpPWpGaD
Bepridil—PDE1A—Disease—HRAS—sarcoma	3.34e-05	6.31e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—ATF1—sarcoma	3.33e-05	6.31e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—ATF1—sarcoma	3.33e-05	6.31e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—SRC—sarcoma	3.32e-05	6.28e-05	CbGpPWpGaD
Bepridil—PDE1B—Immune System—HRAS—sarcoma	3.31e-05	6.25e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—NRAS—sarcoma	3.31e-05	6.25e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—NRAS—sarcoma	3.31e-05	6.25e-05	CbGpPWpGaD
Bepridil—ABCB1—Metabolism—PLCG1—sarcoma	3.29e-05	6.22e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—VEGFA—sarcoma	3.23e-05	6.12e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—SRC—sarcoma	3.2e-05	6.05e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—NRAS—sarcoma	3.19e-05	6.04e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—CREB1—sarcoma	3.16e-05	5.98e-05	CbGpPWpGaD
Bepridil—CYP2D6—Metabolism—PLCG1—sarcoma	3.1e-05	5.86e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—SRC—sarcoma	3.09e-05	5.85e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—SRC—sarcoma	3.09e-05	5.85e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—NRAS—sarcoma	3.08e-05	5.82e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—SRC—sarcoma	3.07e-05	5.81e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—CREB1—sarcoma	3.06e-05	5.78e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—CREB1—sarcoma	3.06e-05	5.78e-05	CbGpPWpGaD
Bepridil—PDE1B—Disease—HRAS—sarcoma	3.05e-05	5.77e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—SRC—sarcoma	3.04e-05	5.75e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—KIT—sarcoma	3.03e-05	5.74e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—NRAS—sarcoma	2.98e-05	5.63e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—NRAS—sarcoma	2.98e-05	5.63e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—MYC—sarcoma	2.98e-05	5.63e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—SRC—sarcoma	2.97e-05	5.62e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—SRC—sarcoma	2.97e-05	5.62e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—VEGFA—sarcoma	2.96e-05	5.6e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—NRAS—sarcoma	2.95e-05	5.59e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—KRAS—sarcoma	2.94e-05	5.56e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—KIT—sarcoma	2.93e-05	5.55e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—KIT—sarcoma	2.93e-05	5.55e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—NRAS—sarcoma	2.92e-05	5.53e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—EGFR—sarcoma	2.91e-05	5.51e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CREB1—sarcoma	2.89e-05	5.46e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—NRAS—sarcoma	2.86e-05	5.41e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—NRAS—sarcoma	2.86e-05	5.41e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—KRAS—sarcoma	2.85e-05	5.38e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—KRAS—sarcoma	2.85e-05	5.38e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—EGFR—sarcoma	2.8e-05	5.3e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—KIT—sarcoma	2.8e-05	5.3e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CREB1—sarcoma	2.79e-05	5.28e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CREB1—sarcoma	2.79e-05	5.28e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—KRAS—sarcoma	2.75e-05	5.2e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—MYC—sarcoma	2.72e-05	5.15e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—EGFR—sarcoma	2.71e-05	5.13e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—EGFR—sarcoma	2.71e-05	5.13e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—KIT—sarcoma	2.71e-05	5.12e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—KIT—sarcoma	2.71e-05	5.12e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IGF1R—sarcoma	2.7e-05	5.11e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—EGFR—sarcoma	2.69e-05	5.09e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CREB1—sarcoma	2.67e-05	5.04e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—EGFR—sarcoma	2.66e-05	5.04e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—KRAS—sarcoma	2.65e-05	5.01e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IGF1R—sarcoma	2.62e-05	4.95e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IGF1R—sarcoma	2.62e-05	4.95e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—TP53—sarcoma	2.61e-05	4.94e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—EGFR—sarcoma	2.6e-05	4.92e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—EGFR—sarcoma	2.6e-05	4.92e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CREB1—sarcoma	2.58e-05	4.88e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CREB1—sarcoma	2.58e-05	4.88e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—FOXO1—sarcoma	2.57e-05	4.87e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PDGFRB—sarcoma	2.57e-05	4.86e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—KRAS—sarcoma	2.56e-05	4.84e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—KRAS—sarcoma	2.56e-05	4.84e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—KRAS—sarcoma	2.54e-05	4.81e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—PDGFRA—sarcoma	2.53e-05	4.78e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—TP53—sarcoma	2.53e-05	4.78e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—TP53—sarcoma	2.53e-05	4.78e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—KRAS—sarcoma	2.52e-05	4.76e-05	CbGpPWpGaD
Bepridil—CALM3—Hemostasis—HRAS—sarcoma	2.5e-05	4.73e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—FOXO1—sarcoma	2.49e-05	4.71e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—FOXO1—sarcoma	2.49e-05	4.71e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PDGFRB—sarcoma	2.49e-05	4.7e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PDGFRB—sarcoma	2.49e-05	4.7e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—KRAS—sarcoma	2.46e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—KRAS—sarcoma	2.46e-05	4.65e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—PDGFRA—sarcoma	2.45e-05	4.63e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—PDGFRA—sarcoma	2.45e-05	4.63e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—TP53—sarcoma	2.44e-05	4.62e-05	CbGpPWpGaD
Bepridil—CALM2—Hemostasis—HRAS—sarcoma	2.42e-05	4.57e-05	CbGpPWpGaD
Bepridil—CALM1—Hemostasis—HRAS—sarcoma	2.42e-05	4.57e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—MDM2—sarcoma	2.39e-05	4.52e-05	CbGpPWpGaD
Bepridil—PDE1A—Signaling Pathways—HRAS—sarcoma	2.34e-05	4.42e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—IL2—sarcoma	2.34e-05	4.42e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—MDM2—sarcoma	2.31e-05	4.37e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—MDM2—sarcoma	2.31e-05	4.37e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—IL2—sarcoma	2.26e-05	4.27e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—IL2—sarcoma	2.26e-05	4.27e-05	CbGpPWpGaD
Bepridil—CALM3—Innate Immune System—HRAS—sarcoma	2.25e-05	4.26e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—TP53—sarcoma	2.24e-05	4.23e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MDM2—sarcoma	2.21e-05	4.17e-05	CbGpPWpGaD
Bepridil—CALM1—Innate Immune System—HRAS—sarcoma	2.18e-05	4.12e-05	CbGpPWpGaD
Bepridil—CALM2—Innate Immune System—HRAS—sarcoma	2.18e-05	4.12e-05	CbGpPWpGaD
Bepridil—CALM3—Adaptive Immune System—HRAS—sarcoma	2.16e-05	4.09e-05	CbGpPWpGaD
Bepridil—PDE1B—Signaling Pathways—HRAS—sarcoma	2.14e-05	4.04e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—IL2—sarcoma	2.13e-05	4.04e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MDM2—sarcoma	2.13e-05	4.04e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MDM2—sarcoma	2.13e-05	4.04e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KDR—sarcoma	2.13e-05	4.03e-05	CbGpPWpGaD
Bepridil—CALM2—Adaptive Immune System—HRAS—sarcoma	2.09e-05	3.95e-05	CbGpPWpGaD
Bepridil—CALM1—Adaptive Immune System—HRAS—sarcoma	2.09e-05	3.95e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—JUN—sarcoma	2.08e-05	3.93e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—IL2—sarcoma	2.06e-05	3.91e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—IL2—sarcoma	2.06e-05	3.91e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—CTNNB1—sarcoma	2.06e-05	3.9e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KDR—sarcoma	2.06e-05	3.9e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KDR—sarcoma	2.06e-05	3.9e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—JUN—sarcoma	2.01e-05	3.8e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—JUN—sarcoma	2.01e-05	3.8e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—CTNNB1—sarcoma	1.99e-05	3.77e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—CTNNB1—sarcoma	1.99e-05	3.77e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KIT—sarcoma	1.96e-05	3.71e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—NRAS—sarcoma	1.96e-05	3.71e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—CTNNB1—sarcoma	1.9e-05	3.6e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KIT—sarcoma	1.9e-05	3.59e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KIT—sarcoma	1.9e-05	3.59e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—NRAS—sarcoma	1.9e-05	3.59e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—NRAS—sarcoma	1.9e-05	3.59e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CREB1—sarcoma	1.87e-05	3.53e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—SRC—sarcoma	1.86e-05	3.52e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—CTNNB1—sarcoma	1.84e-05	3.48e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—CTNNB1—sarcoma	1.84e-05	3.48e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CREB1—sarcoma	1.81e-05	3.42e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CREB1—sarcoma	1.81e-05	3.42e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—SRC—sarcoma	1.8e-05	3.41e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—SRC—sarcoma	1.8e-05	3.41e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—NRAS—sarcoma	1.79e-05	3.39e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—EGFR—sarcoma	1.79e-05	3.38e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—NRAS—sarcoma	1.73e-05	3.28e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—NRAS—sarcoma	1.73e-05	3.28e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—EGFR—sarcoma	1.73e-05	3.27e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—EGFR—sarcoma	1.73e-05	3.27e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—SRC—sarcoma	1.72e-05	3.25e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—KRAS—sarcoma	1.69e-05	3.19e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—SRC—sarcoma	1.66e-05	3.15e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—SRC—sarcoma	1.66e-05	3.15e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—NRAS—sarcoma	1.65e-05	3.13e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—KRAS—sarcoma	1.63e-05	3.09e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—KRAS—sarcoma	1.63e-05	3.09e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—EGFR—sarcoma	1.63e-05	3.09e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—NRAS—sarcoma	1.6e-05	3.03e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—NRAS—sarcoma	1.6e-05	3.03e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—EGFR—sarcoma	1.58e-05	2.99e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—EGFR—sarcoma	1.58e-05	2.99e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MDM2—sarcoma	1.54e-05	2.92e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—KRAS—sarcoma	1.54e-05	2.92e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—MYC—sarcoma	1.54e-05	2.91e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—EGFR—sarcoma	1.51e-05	2.85e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MDM2—sarcoma	1.49e-05	2.83e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MDM2—sarcoma	1.49e-05	2.83e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—KRAS—sarcoma	1.49e-05	2.82e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—KRAS—sarcoma	1.49e-05	2.82e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—MYC—sarcoma	1.49e-05	2.82e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—MYC—sarcoma	1.49e-05	2.82e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—EGFR—sarcoma	1.46e-05	2.76e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—EGFR—sarcoma	1.46e-05	2.76e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling by GPCR—HRAS—sarcoma	1.43e-05	2.71e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—KRAS—sarcoma	1.42e-05	2.69e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling by GPCR—HRAS—sarcoma	1.39e-05	2.63e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling by GPCR—HRAS—sarcoma	1.39e-05	2.63e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—IL2—sarcoma	1.38e-05	2.61e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—KRAS—sarcoma	1.38e-05	2.61e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—KRAS—sarcoma	1.38e-05	2.61e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CCND1—sarcoma	1.35e-05	2.54e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—JUN—sarcoma	1.34e-05	2.54e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—IL2—sarcoma	1.34e-05	2.53e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—IL2—sarcoma	1.34e-05	2.53e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—CTNNB1—sarcoma	1.33e-05	2.52e-05	CbGpPWpGaD
Bepridil—CALM3—Immune System—HRAS—sarcoma	1.31e-05	2.48e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CCND1—sarcoma	1.3e-05	2.46e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CCND1—sarcoma	1.3e-05	2.46e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—JUN—sarcoma	1.3e-05	2.46e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—JUN—sarcoma	1.3e-05	2.46e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—CTNNB1—sarcoma	1.29e-05	2.44e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—CTNNB1—sarcoma	1.29e-05	2.44e-05	CbGpPWpGaD
Bepridil—CALM2—Immune System—HRAS—sarcoma	1.27e-05	2.4e-05	CbGpPWpGaD
Bepridil—CALM1—Immune System—HRAS—sarcoma	1.27e-05	2.4e-05	CbGpPWpGaD
Bepridil—CALM3—Disease—HRAS—sarcoma	1.21e-05	2.29e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—SRC—sarcoma	1.2e-05	2.28e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—VEGFA—sarcoma	1.17e-05	2.22e-05	CbGpPWpGaD
Bepridil—CALM2—Disease—HRAS—sarcoma	1.17e-05	2.21e-05	CbGpPWpGaD
Bepridil—CALM1—Disease—HRAS—sarcoma	1.17e-05	2.21e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—SRC—sarcoma	1.16e-05	2.2e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—SRC—sarcoma	1.16e-05	2.2e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—NRAS—sarcoma	1.16e-05	2.19e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—VEGFA—sarcoma	1.13e-05	2.15e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—VEGFA—sarcoma	1.13e-05	2.15e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—NRAS—sarcoma	1.12e-05	2.12e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—NRAS—sarcoma	1.12e-05	2.12e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—MYC—sarcoma	1.08e-05	2.04e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—EGFR—sarcoma	1.06e-05	2e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—MYC—sarcoma	1.04e-05	1.97e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—MYC—sarcoma	1.04e-05	1.97e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—EGFR—sarcoma	1.02e-05	1.93e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—EGFR—sarcoma	1.02e-05	1.93e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—KRAS—sarcoma	9.97e-06	1.89e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—KRAS—sarcoma	9.65e-06	1.82e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—KRAS—sarcoma	9.65e-06	1.82e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—TP53—sarcoma	8.86e-06	1.68e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—TP53—sarcoma	8.57e-06	1.62e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—TP53—sarcoma	8.57e-06	1.62e-05	CbGpPWpGaD
Bepridil—CALM3—Signaling Pathways—HRAS—sarcoma	8.48e-06	1.6e-05	CbGpPWpGaD
Bepridil—CALM2—Signaling Pathways—HRAS—sarcoma	8.2e-06	1.55e-05	CbGpPWpGaD
Bepridil—CALM1—Signaling Pathways—HRAS—sarcoma	8.2e-06	1.55e-05	CbGpPWpGaD
